In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type Wuhan and the Delta variant (B.1.617.2). Convalescent sera, as well as sera obtained from participants who received two or three doses of mRNA vaccines (Moderna-mRNA-1273® or Pfizer-BNT162b2®), were used for comparison in this study. Our data demonstrate that both Delta, as well as Omicron variants, exhibit a higher affinity for the receptor ACE2, facilitating infection and causing antibody escape by receptor affinity (affinity escape), due to the reduced ability of antibodies to compete with RBD-receptor interacti...
Background and MethodsThe SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) Omicron (B.1....
New variants of SARS-CoV-2 continue to emerge and evade immunity. We isolated SARS-CoV-2 temporally ...
Vaccination with the primary two-dose series of SARS-CoV-2 mRNA protects against infection with the ...
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1...
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1...
On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announce...
On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announce...
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021(1) and has multiple mutations in its spike prote...
Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to...
The ongoing evolution of SARS-CoV-2 has resulted in the emergence of Omicron, which displays strikin...
Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to...
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1–3...
Background: Since the first COVID-19 outbreak, variants of SARS-CoV-2 have continued to dominate the...
Highly transmissible Omicron variants of SARS-CoV-2 currently dominate globally. Here, we compare ne...
The SARS-CoV-2 variant Omicron has spread world-wide and is responsible for rapid increases in infec...
Background and MethodsThe SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) Omicron (B.1....
New variants of SARS-CoV-2 continue to emerge and evade immunity. We isolated SARS-CoV-2 temporally ...
Vaccination with the primary two-dose series of SARS-CoV-2 mRNA protects against infection with the ...
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1...
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1...
On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announce...
On 24th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529 was announce...
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021(1) and has multiple mutations in its spike prote...
Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to...
The ongoing evolution of SARS-CoV-2 has resulted in the emergence of Omicron, which displays strikin...
Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to...
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and South Africa1–3...
Background: Since the first COVID-19 outbreak, variants of SARS-CoV-2 have continued to dominate the...
Highly transmissible Omicron variants of SARS-CoV-2 currently dominate globally. Here, we compare ne...
The SARS-CoV-2 variant Omicron has spread world-wide and is responsible for rapid increases in infec...
Background and MethodsThe SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) Omicron (B.1....
New variants of SARS-CoV-2 continue to emerge and evade immunity. We isolated SARS-CoV-2 temporally ...
Vaccination with the primary two-dose series of SARS-CoV-2 mRNA protects against infection with the ...